<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365270</url>
  </required_header>
  <id_info>
    <org_study_id>FDASU-REC IM 011730</org_study_id>
    <nct_id>NCT04365270</nct_id>
  </id_info>
  <brief_title>Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer</brief_title>
  <official_title>The Antimicrobial Activity and Clinical Performance of Chitosan-modified Glass Ionomer: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized clinical trial that assesses the clinical success and the
      antibacterial effect on carious dentine of glass ionomer when modified with Chitosan and/or
      Titanium dioxide nano particles vs the control group of modification with Chlorhexidine as
      control when used in primary molars
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited from the acquitted to the clinic of pediatric dentistry
      department , Faculty of Dentistry of Ain Shams University. random allocation of the
      participants where indirect pulp capping is indicated so that modified Glass ionomer would be
      used as the filling material.

      partial removal of caries is done then caries sample would be taken and sent for a
      microbiological evaluation and then, cavity dimensions is recoded, finally placement of the
      modified glass ionomer in the prepared cavity.

      In a total period of 9 months the patients will be followed every 3 months for clinical
      evaluation and in the final visit the filling would be removed and another bacterial sample
      would be taken for comparison, then a permanent filling is placed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 15, 2019</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>All participants and assessors will be masked,the wil just deal with the randomized numbers.
except the care provider because the materials consistency before mixing is obvious in 2 of the 3 groups</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Antibacterial</measure>
    <time_frame>9 months</time_frame>
    <description>Dentin samples incubated on 2 culture mediums and total bacterial count by counting colony forming units will be counted. Higher number means Less antibacterial effect</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical performance</measure>
    <time_frame>followup 9 months</time_frame>
    <description>&quot;Modified United States Public Health Service Ryge Criteria&quot; for Direct Clinical Evaluation and rating of Restoration.measuring color match, anatomic contour, marginal integrity, cavosurface marginal discoloration, secondary caries, surface texture, gross fracture.
each outcome will be graded Alpha(A) for the highest score, Bravo(b) for moderate score, and Charlie(C) for the lowest score.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Reversible Pulpitis</condition>
  <condition>Pulpitis</condition>
  <condition>Caries,Dental</condition>
  <condition>Caries Class I</condition>
  <condition>Caries; Dentin</condition>
  <condition>Caries</condition>
  <arm_group>
    <arm_group_label>Chitosan Glass ionomer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>purified low molecular weight and viscosity chitosan will be dissolved in 0.1 mol/L acetic acid to be used to modify the stock liquid provided with the glassionomer Fuji IX to have 10% v/v chitosan.
will be placed in the prepared cavity over the last layer of caries</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chitosan/Titanium dioxide nanoparticles Glass ionomer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The stock liquid provided with the glassionomer Fuji IX will be modified with 10%v/v purified low molecular weight and viscosity chitosan will be dissolved in 0.1 mol/L acetic acid.
The Powder will be modified with 3% titanium dioxide nanoparticles will be placed in the prepared cavity over the last layer of caries</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chlorhexidine glass ionomer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Chlorhexidine Diacetate will be added to the powder of Fuji IX with 0.5% v/v</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glass ionomer</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Stock powder and liquid Fuji IX from GC japan</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glass Ionomer</intervention_name>
    <description>Glass ionomer filling material would be modified accordingly or used as is</description>
    <arm_group_label>Chitosan Glass ionomer</arm_group_label>
    <arm_group_label>Chitosan/Titanium dioxide nanoparticles Glass ionomer</arm_group_label>
    <arm_group_label>Chlorhexidine glass ionomer</arm_group_label>
    <arm_group_label>Glass ionomer</arm_group_label>
    <other_name>Fuji IX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chitosan Low Molecular Weight (20-200 Mpa.S)</intervention_name>
    <description>deacetylated chitin, poly(D-glucosamine) purified by dissolving in 0.1 mol/L acetic acid, then precipitated in 0.1 mol/L sodium hydroxide and the precipitate will be washed with ethanol/water (70/30 v/v) mixture followed by freeze drying</description>
    <arm_group_label>Chitosan Glass ionomer</arm_group_label>
    <arm_group_label>Chitosan/Titanium dioxide nanoparticles Glass ionomer</arm_group_label>
    <other_name>Aldrich, cat#448869, lot #STBG9041</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine Diacetate</intervention_name>
    <description>Chlorhexidine antibacterial effect to be compared by Sigma-aldrich PHR 1222 , lot#LRAB3716</description>
    <arm_group_label>Chlorhexidine glass ionomer</arm_group_label>
    <other_name>chlorhexidine acetate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Titanium Dioxide</intervention_name>
    <description>Titanium(IV) oxide,nanopowder, 21 nm primary particle size (TEM), &gt;99.5% trace metals basis cat#718467 Lot#MKCB6332 Lot #MKCB6332</description>
    <arm_group_label>Chitosan/Titanium dioxide nanoparticles Glass ionomer</arm_group_label>
    <other_name>Titanium(IV) oxide</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The teeth will be primary molars selected from patients presented to the outpatient clinic
        that are

          -  Healthy patients.

          -  Age: 4-8 years.

          -  Children having at least one primary molar with only occlusal caries having dentine
             lesions wide enough for the smallest excavator to enter (Ã˜=0.9 mm).

        Exclusion Criteria:

          -  Teeth with pulp involvement, those suffering from pain, irreversible pulpits or pulp
             necrosis.

          -  Children with systemic diseases.

          -  Patients with history of active para-functional oral habits, xerostomia.

          -  Patients who will have difficulties in cooperating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>8 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariem Wassel, Assistant professor</last_name>
    <role>Study Chair</role>
    <affiliation>Ainshams University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Noha Kabil, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Ainshams university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>omar A Hodhod, Dentist</last_name>
    <role>Principal Investigator</role>
    <affiliation>British University in cairo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Dentistry, Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>1156</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Mulder R, Anderson-Small C. Ion release of chitosan and nanodiamond modified glass ionomer restorative cements. Clin Cosmet Investig Dent. 2019 Sep 6;11:313-320. doi: 10.2147/CCIDE.S220089. eCollection 2019.</citation>
    <PMID>31686917</PMID>
  </reference>
  <reference>
    <citation>Wassel MO, Khattab MA. Antibacterial activity against Streptococcus mutans and inhibition of bacterial induced enamel demineralization of propolis, miswak, and chitosan nanoparticles based dental varnishes. J Adv Res. 2017 Jul;8(4):387-392. doi: 10.1016/j.jare.2017.05.006. Epub 2017 May 17.</citation>
    <PMID>28560054</PMID>
  </reference>
  <results_reference>
    <citation>Ibrahim MA, Meera Priyadarshini B, Neo J, Fawzy AS. Characterization of Chitosan/TiO(2) Nano-Powder Modified Glass-Ionomer Cement for Restorative Dental Applications. J Esthet Restor Dent. 2017 Apr;29(2):146-156. doi: 10.1111/jerd.12282. Epub 2017 Feb 12.</citation>
    <PMID>28190299</PMID>
  </results_reference>
  <results_reference>
    <citation>Ibrahim MA, Neo J, Esguerra RJ, Fawzy AS. Characterization of antibacterial and adhesion properties of chitosan-modified glass ionomer cement. J Biomater Appl. 2015 Oct;30(4):409-19. doi: 10.1177/0885328215589672. Epub 2015 Jun 15.</citation>
    <PMID>26079388</PMID>
  </results_reference>
  <results_reference>
    <citation>Kabil NS, Badran AS, Wassel MO. Effect of the addition of chlorhexidine and miswak extract on the clinical performance and antibacterial properties of conventional glass ionomer: an in vivo study. Int J Paediatr Dent. 2017 Sep;27(5):380-387. doi: 10.1111/ipd.12273. Epub 2016 Oct 21.</citation>
    <PMID>27766712</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>December 6, 2019</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>July 10, 2020</last_update_submitted>
  <last_update_submitted_qc>July 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>British University In Egypt</investigator_affiliation>
    <investigator_full_name>Omar Assem Hodhod</investigator_full_name>
    <investigator_title>Principal Investigator,Teaching Assistant ,Dentist</investigator_title>
  </responsible_party>
  <keyword>Glass ionomer</keyword>
  <keyword>Chitosan</keyword>
  <keyword>Titanium dioxide</keyword>
  <keyword>Titanium dioxide nanoparticles</keyword>
  <keyword>Chlorhexidine</keyword>
  <keyword>indirect pulp capping</keyword>
  <keyword>Alternative restorative technique</keyword>
  <keyword>stepwise caries excavation</keyword>
  <keyword>antibacterial restorative</keyword>
  <keyword>incomplete caries removal</keyword>
  <keyword>primary molars</keyword>
  <keyword>early childhood caries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulpitis</mesh_term>
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Titanium dioxide</mesh_term>
    <mesh_term>Chitosan</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

